Test Price
2,800 AED✅ Home Collection Available
HSPB8 Gene Neuronopathy (Distal Hereditary Motor Neuropathy Type 2A) Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جينات HSPB8 لاعتلال العصبون المحرك الوراثي البعيد من النوع 2A في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary | ملخص تنفيذي
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
- Premium Logistics: Paid Hospital‑Grade Home Collection via ISO Certified Cold‑Chain Home Collection and VIP Mobile Phlebotomy.
- Clinical Guidance: Telephonic Post‑Test Clinical Guidance in result interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
الملخص التنفيذي: يقدم هذا الفحص التحليل الجيني المتطور لجين HSPB8 للكشف عن الطفرات المسببة لاعتلال العصبون المحرك البعيد الوراثي من النوع 2A، بضمان دقة تشخيصية تصل إلى 99.9% عبر مختبر معتمد دوليًا وفق معيار ISO، مع خدمة سحب منزلي متميزة على مدار الساعة واستشارة جينية عن بُعد بعد النتائج.
Overview
The HSPB8 Genetic Test sequences the entire coding region of the HSPB8 gene to identify pathogenic variants responsible for distal hereditary motor neuropathy type 2A (dHMN2A) – a rare, progressive neuromuscular disorder. This test provides essential molecular diagnosis, supports accurate genetic counseling, and helps differentiate dHMN2A from other hereditary neuropathies.
| Feature | Our HSPB8 NGS Test | Closest Alternative |
|---|---|---|
| Methodology | Next‑Generation Sequencing (NGS) – full gene coverage | Sanger sequencing of selected exons only |
| Diagnostic Yield | >99.9% analytical sensitivity for all coding variants | ~85% – may miss deep intronic or regulatory mutations |
| Turnaround Time | 3–4 weeks | 4–6 weeks |
| Result Utility | Comprehensive report aligned with 2026 DHA recommendations | Limited variant interpretation, often requiring reflex testing |
Physician Insight & Safety Protocol
Hereditary motor neuropathies can present with subtle, slowly progressive weakness; this genetic test is a powerful tool but must be correlated with a detailed neurological examination and family history. A negative result does not exclude other genetic or acquired neuropathies, and variants of uncertain significance require expert interpretation. I strongly recommend pre‑ and post‑test genetic counseling to fully understand the implications for you and your family.
⛔ Do not discontinue any prescribed medication without consulting your doctor.
Safety Exclusion Criteria & Emergency Red Flags
- Exclusion Criteria: Individuals under 18 years without legally authorized guardian consent (per CDS Law 2026); inability to provide informed consent; acute psychiatric instability affecting decision‑making capacity.
- ER Red Flags: Sudden worsening of muscle weakness, difficulty breathing or swallowing, acute new‑onset foot drop or hand atrophy, or any rapidly progressive neurological deficit – seek immediate emergency medical attention.
Patient FAQ & Clinical Guidance
Q: What is the HSPB8 gene test and why do I need it?
A: HSPB8 gene sequencing detects pathogenic mutations in the HSPB8 gene causing distal hereditary motor neuropathy type 2A, enabling accurate diagnosis and personalized care. This test confirms the molecular cause of progressive distal limb weakness and atrophy, differentiates it from other neuromuscular conditions, and informs family screening and reproductive planning. A genetic counseling session is arranged beforehand to map your family pedigree and discuss potential outcomes.
س: ما هو فحص جين HSPB8 ولماذا أحتاج إليه؟
ج: يكشف فحص تتابع جين HSPB8 عن الطفرات الممرضة المسببة لاعتلال العصبون المحرك البعيد الوراثي من النوع 2A، مما يتيح تشخيصًا دقيقًا ورعاية طبية مخصصة. يُجرى الفحص بعد جلسة استشارة جينية لرسم شجرة العائلة وتقدير المخاطر الوراثية.
Q: How is the sample collected and when will I get the results?
A: A small blood sample, extracted DNA, or a dried blood spot on an FTA card is collected comfortably at your home by a certified phlebotomist; results are delivered within 3–4 weeks. Our VIP mobile phlebotomy team operates daily from 8 AM to 11 PM, ensuring specimen integrity via cold‑chain transport. You will receive a secure digital report and a post‑test teleconsultation to interpret your findings.
س: كيف تُؤخذ العينة ومتى تظهر النتائج؟
ج: تُسحب عينة دم صغيرة أو حمض نووي مستخلص أو بقعة دم جافة على بطاقة FTA منزليًا على يد اختصاصي معتمد؛ وتصدر النتائج خلال 3 إلى 4 أسابيع. تشمل الخدمة استشارة هاتفية لتفسير التقرير بعد الفحص.
Q: Is the HSPB8 test covered by insurance in the UAE?
A: Insurance coverage varies by provider and policy; we offer direct billing verification via WhatsApp at +971 54 548 8731 before scheduling the. Our team will check your benefits under DHA‑regulated health plans and assist with pre‑authorization if required. Self‑pay options are also available at a transparent all‑inclusive rate of 2800 AED.
س: هل يغطي التأمين الصحي هذا الفحص في الإمارات؟
ج: تختلف تغطية التأمين وفقًا للسياسة وبوليصة كل مريض؛ نوفر خدمة التحقق المباشر من التغطية عبر واتساب على الرقم +971 54 548 8731 قبل إجراء الفحص. السعر الإجمالي للفحص 2800 درهم في حال الدفع الذاتي.
Compliance & Accreditation
This service complies with UAE Federal Decree‑Law No. 41 of 2024 (Art. 87), the Child Digital Safety (CDS) Law 2026 for minors, and the UAE Personal Data Protection Law (PDPL). Laboratory operations follow ISO 9001:2015 standards (Cert: INT/EGQ/2509DA/3139). All genetic data is processed within a secure, DHA‑adherent infrastructure.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians